Cigna Denied Your CGM, Insulin Pump, or Diabetes Supplies?

Diabetes management requires continuous access to supplies and medications — continuous glucose monitors (CGMs), insulin pumps, test strips, and increasingly, GLP-1 receptor agonists like Ozempic and Mounjaro. Cigna's coverage criteria for these tools can be restrictive, and Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization denials are common. If your diabetes supply or medication claim was denied, here's how to fight back effectively.

Cigna's CGM Coverage Criteria

Continuous glucose monitors have transformed diabetes management, but Cigna applies specific clinical criteria that not all patients automatically meet. Cigna's standard CGM policy typically requires:

• A diagnosis of diabetes mellitus (Type 1 or Type 2)
• For Type 1: coverage is generally more accessible, as intensive insulin management is standard of care
• For Type 2: Cigna often requires documentation of intensive insulin therapy (multiple daily injections or insulin pump use) and evidence that CGM is necessary for glycemic management
• A prescribing physician (endocrinologist or primary care) who will interpret the CGM data

Cigna has historically been more restrictive with CGM coverage for non-insulin-dependent Type 2 patients, even as clinical evidence increasingly supports broader use. The American Diabetes Association's Standards of Care support CGM for a wider population than Cigna's policy often reflects.

If Cigna denied your CGM: Your physician's letter of medical necessity should explain how CGM will improve your glycemic control, reduce hypoglycemic episodes, or facilitate medication adjustments that cannot be achieved with fingerstick monitoring alone.

Insulin Pump Prior Authorization

Insulin pumps (continuous subcutaneous insulin infusion devices) require prior authorization through Cigna. Common denial reasons include:

Documentation of failed MDI therapy. Cigna typically requires evidence that the patient has been using multiple daily injections (MDI) with inadequate glucose control before approving an insulin pump.

C-peptide and Type 1 documentation. For patients with Type 1 diabetes, Cigna may require C-peptide testing to confirm insulin deficiency.

Training and follow-up requirements. Cigna may require documentation that the patient will receive pump training and ongoing follow-up from a qualified diabetes care provider.

Insufficient HbA1c evidence. If your HbA1c records do not show suboptimal control despite MDI, Cigna reviewers may question whether the pump represents a necessary upgrade.

GLP-1 Drug Tier Placement and Step Therapy

GLP-1 receptor agonists — including semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), and liraglutide (Victoza) — have become central to Type 2 diabetes and weight management. However, Cigna's Express Scripts formulary places many of these medications on higher tiers or subjects them to step therapy requirements.

Common issues include:

Step therapy requiring metformin and/or sulfonylurea first. Cigna and Express Scripts may require that a patient try first-line agents like metformin before approving a GLP-1. For patients with contraindications to metformin or specific cardiovascular risk profiles, a step therapy exception is appropriate.

GLP-1 vs. weight loss indication. Cigna distinguishes between GLP-1 drugs prescribed for diabetes (more likely covered) and those prescribed solely for weight loss. Wegovy and Zepbound, FDA-approved specifically for obesity, face different coverage rules than their diabetes-indicated counterparts, even when the drug is identical.

Formulary non-coverage. Some GLP-1 agents are not on the Cigna/Express Scripts formulary for your specific plan year. A formulary exception requires clinical evidence that the formulary alternative is inadequate.

Appealing a Diabetes Supply Denial

Step 1: Identify the specific denial reason. Your EOB and denial letter should state whether the denial is for PA criteria not met, step therapy, non-formulary status, or another reason.

Step 2: Have your endocrinologist or prescribing physician submit a detailed letter of medical necessity. The letter should reference your HbA1c history, documented hypoglycemic episodes (for CGM/pump), specific clinical indications for the requested product, and why alternatives are not adequate.

Step 3: Request a peer-to-peer review. Your physician can call 1-800-88-CIGNA (1-800-882-4462) to speak directly with the Cigna clinical reviewer. Peer-to-peer reviews for diabetes supplies often resolve documentation gaps efficiently.

Step 4: File a formal internal appeal. Submit within 180 days of the denial to: Cigna Appeals, PO Box 188011, Chattanooga, TN 37422. Include clinical literature supporting your treatment when Cigna's policy lags behind current ADA guidelines.

Step 5: Use myCigna.com. Many pharmacy-related appeals can be initiated through the myCigna member portal under the pharmacy benefit section, which connects to the Express Scripts appeal system.

Step 6: Request external IRO review. If the internal appeal is denied, External Independent Review: Complete Guide" class="auto-link">external review provides an independent clinical assessment. External reviewers apply current diabetes care standards, which may be more favorable than Cigna's proprietary criteria.

The ADA Standards Advantage

The American Diabetes Association publishes annual Standards of Medical Care in Diabetes, which represent the clinical consensus on appropriate diabetes management. When Cigna's coverage criteria are inconsistent with ADA Standards — for example, restricting CGM to insulin-dependent patients despite ADA recommendations for broader use — citing the ADA Standards in your appeal creates a strong evidence-based argument.

Fight Back With ClaimBack

Cigna's diabetes supply denials often reflect criteria that trail clinical evidence. ClaimBack helps you build an appeal that aligns with current ADA and endocrinology standards to get your CGM, pump, or GLP-1 covered.

Start your Cigna diabetes supply appeal at ClaimBack

Related Reading

• What Is Medical Necessity?
• How to Write an Insurance Appeal Letter
• Common Reasons Insurance Claims Are Denied